Figure 2. Change From Baseline in Cohen-Mansfield Agitation Inventory (CMAI) Total Score (Primary End Point) and Clinical Global Impression–Severity of Illness (CGI-S) Score as Related to Agitation (Key Secondary End Point): Efficacy Sample.

Baseline mean CMAI total scores: brexpiprazole, 80.6; placebo, 79.2. Baseline mean CGI-S scores: brexpiprazole, 4.7; placebo, 4.7. Footnotes indicate nominal P values with no adjustment for multiplicity.

^aP < .01 vs placebo, mixed model for repeated measures.

^bP < .001 vs placebo, mixed model for repeated measures.